Last Price$70.5(2.1%)
Market Cap$13.4B
78.6%
Industry median - 82.6%
5Y Historical average - 75.7%
19.0%
Industry median - (165.5%)
5Y Historical average - 4.0%
16.7%
Industry median - (175.6%)
5Y Historical average - 3.8%
111.4%
Industry median - 86.2%
5Y Historical average - 64.4%
BMRN Profitability Rating
BMRN Profitability rating
8.8
BMRN Profitability rating performance
BMRN Profitability Metrics
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Competing with BMRN Profitability
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Profitability rating | Gross Profit margin (LTM) | EBIT margin (LTM) | EBITDA margin (LTM) | Net Income margin (LTM) | FCF margin (LTM) | Earnings quality (FCF to Net Income) |
$13.4B | 8.8 | 78.6% | 16.2% | 22.8% | 15.0% | 16.7% | 111.4% | |
$124.8B | 6.8 | 86.1% | (2.2%) | 4.4% | (4.9%) | (7.2%) | 147.6% | |
$77.0B | 8.1 | 84.5% | 28.3% | 33.9% | 31.1% | 25.3% | 81.5% | |
$34.4B | 5.9 | 86.8% | (17.1%) | (2.1%) | (4.5%) | (9.4%) | 103.2% | |
$30.7B | 5.3 | 85.6% | (7.9%) | (8.6%) | (12.4%) | (1.9%) | 15.3% | |
$24.0B | 6.3 | 80.3% | (47.8%) | (13.2%) | (24.2%) | (8.4%) | 33.9% | |
$14.5B | 8.4 | 73.9% | 57.1% | 81.0% | 37.9% | 122.3% | 208.1% | |
$14.2B | 7.0 | 92.3% | 1.5% | 6.2% | 0.8% | 5.5% | 721.1% | |
$13.8B | 9.1 | 89.2% | 47.9% | 55.9% | 41.5% | 37.6% | 90.4% | |
$13.3B | 5.7 | N/A | N/A | N/A | N/A | N/A | 64.2% | |
$1,846.9M | 5.8 | 83.7% | (26.3%) | (22.0%) | (95.0%) | (31.4%) | 121.0% |
FAQ
What is the BioMarin Pharmaceutical Inc. (BMRN) gross profit margin?
The BioMarin Pharmaceutical Inc. (BMRN) gross profit margin is 78.6%, compared to the industry median of 82.6% and the 5-year historical average of 75.7%.
What is the BioMarin Pharmaceutical Inc. (BMRN) operating income margin?
The BioMarin Pharmaceutical Inc. (BMRN) operating income margin is 19.0%, compared to the industry median of (165.5%)) and the 5-year historical average of 4.0%.
What is the BioMarin Pharmaceutical Inc. (BMRN) Free Cash Flow (FCF) margin?
The BioMarin Pharmaceutical Inc. (BMRN) Free Cash Flow margin is 16.7%, compared to the industry median of (175.6%) and the 5-year historical average of 3.8%.
What is the BioMarin Pharmaceutical Inc. (BMRN) earnings quality?
The BioMarin Pharmaceutical Inc. (BMRN) earnings quality is 111.4%, compared to the industry median of 86.2% and the 5-year historical average of 64.4%.